All In Biotech

Drug Trial Radar · NCT03068481

Clinical Study of KDT-3594 in Healthy Adult Males and Patients With Parkinson's Disease

A Phase I Clinical Study of KDT-3594 in Healthy Adult Males and Patients With Parkinson's Disease

Last checked: Nov 20, 2026Latest source record: Apr 1, 2019 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

36

Actual

Start

Feb 20, 2017

Primary completion

Aug 13, 2018

Study completion Aug 13, 2018

Sponsor

Sponsor type
Industry
First posted
Mar 1, 2017

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Randomized
Model
Parallel
Masking
Single (participant)
Primary purpose
Other
FDA-regulated drug
No
Who can join
All sexes, from 20 years, up to 74 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

The purpose of this study in healthy adult males is to investigate safety and pharmacokinetics of single and multiple oral doses of KDT-3594. The purpose of this study in patients with Parkinson's disease is to investigate safety and pharmacokinetics of single and multiple oral doses of KDT-3594. The exploratory efficacy of KDT-3594 will also be investigated.

Conditions

  • Parkinson Disease

Interventions

  • KDT-3594Drug

    Oral administration

  • PlaceboDrug

    Oral administration

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Occurrence of adverse eventsTime frame: Up to 15 days after last administration
  2. Plasma pharmacokinetic parameter of KDT-3594 and main metabolites: CmaxTime frame: Up to 336 hours after last administration
  3. Plasma pharmacokinetic parameter of KDT-3594 and main metabolites: AUCTime frame: Up to 336 hours after last administration

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Site not named

    Kyushu and Other Regions, Japan

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.